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1 ABSTRACT (250 WORDS) 24 
Introduction 25 
More than one in three older adults (≥65 years) fall within a two-year period. Over 26 
one third of cancer diagnoses are among people aged ≥75 years. Falls research in the UK 27 
cancer population is limited and contradictory. The aim of this study was to explore the 28 
association between a cancer diagnosis and incidence of falls in older adults in England.  29 
 30 
Methods  31 
Data were extracted from the English Longitudinal Study of Ageing (an ongoing panel 32 
study) collected between 2002 and 2014, consisting of a representative cohort of older 33 
adults living in England. Baseline data were collected within two-years of a cancer diagnosis. 34 
Falls data were extracted from the subsequent two-year period. The unexposed group 35 
included those with no chronic conditions. The fully adjusted logistic regression analysis 36 
model included age, sex, wealth, and education level as covariates. We defined odds ratios 37 
between 0.67 and 1.5 as the region of practical equivalence.  38 
 39 
Results 40 
A total of 139 people had a type of cancer (exposed group) (Breast=18.7%, Colon, 41 
Rectum or Bowel=14.4%, Melanoma or Skin=7.2%, Lung=4.3%, Somewhere else=51.8%) 42 
(70.6±7.1 years; 58.3% male) with 3,899 in the unexposed group (69.5±7.3 years; 54.6% 43 
male). The fully-adjusted odds ratio was 1.21 (95% CI: 0.81 to 1.82; P=0.348). The 44 
probability of falling among the exposed group was 22.7% versus 19.5% for the unexposed 45 





The cancer and control groups were not statistically equivalent for falls incidence, 49 
and a meaningful positive association between cancer and falls cannot be ruled out. Further 50 
research is required to elucidate this relationship. 51 
 52 
Key Words 53 
Cancer, Older adults, Ageing, Falls, English Longitudinal Study of Ageing. 54 
  55 
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2 INTRODUCTION 56 
Globally, cancer is a major burden of disease. In the UK, around 450 deaths per day 57 
are attributed to some form of cancer [1], resulting in it being the leading cause of deaths [2]. 58 
Almost 990 people were newly diagnosed with some form of cancer every day in the UK 59 
between 2013 and 2015 [3].  60 
 Locations, types, and stages of cancer contribute to the type and severity of 61 
symptoms an individual may experience; therefore, it is difficult to identify common cancer 62 
symptoms in general. That said, the most common symptoms include fatigue, 63 
breathlessness, a change in bowel habits, loss of appetite, unusual lumps, coughing and 64 
unexpected aches and pains [4, 5]. Cancer surgery has been shown to cause symptoms 65 
such as dyspnoea, decreased functionality and decreased postural stability, resulting in 66 
decreased physical activity levels [6, 7, 8]. Adjuvant therapy, such as chemotherapy, has 67 
also been shown to affect motor and sensory function [9, 10]. 68 
It is well-known that incidence of falls is greater among older adults than a younger 69 
population [11, 12], with 18% of young adults (20-45 years old), 21% of middle-aged adults 70 
(46-65 years old) and 35% of older aged adults (>65 years old) falling within a two-year 71 
period [13]. People diagnosed with cancer are often older adults, with around one third of 72 
cancer diagnoses among those aged 75 years or older [1]. There are contradictory findings 73 
with regards to incidence of falls between those with and without cancer. Numerous studies 74 
have shown an increase in fall incidence among people with cancer (up to 50%) [14, 15, 16], 75 
whilst others report a greater incidence of falls among those without cancer or no difference 76 
between groups (No cancer: 27.6-42.2%; Cancer with treatment: 30.3-33.0%; Cancer 77 
without treatment: 22.0-24.7%) [17, 18]. These findings might be due to the variation that 78 
exists in types of cancer (e.g. breast, lung and prostate), the symptoms of these, and the 79 
side-effects (e.g. dyspnoea, fatigue and pain) of associated treatments (e.g. surgery and 80 
chemotherapy). For example, people with lung cancer might be at a greater risk of falling 81 
5 
 
due to the side-effects of thoracic surgery, including dyspnoea due to reduced lung capacity, 82 
and an altered centre of gravity due to anatomical changes.  83 
It is estimated that falls among older adults cost the National Health Service in the 84 
UK more than £2.3 billion per year [19]. Falls result in functional decline, decreased quality 85 
of life and in some cases death, in older adults and people with cancer [12, 17, 20]. One in 86 
10 falls among older adults, with and without cancer, will result in a serious injury, such as 87 
fractures, dislocation, brain injury or soft tissue damage [21, 22, 23]. Hip fractures are a 88 
major cause of mortality in older adults [24, 25]. Psychological distress is another factor that 89 
is a result of a fall among an older population, which includes fear, loss of confidence, 90 
activity avoidance, loss of independence, disability, insecurity, altered body image and 91 
anxiety [26, 27].  92 
The English Longitudinal Study of Ageing (ELSA) is an ongoing longitudinal panel 93 
study, consisting of a representative cohort of older adults living in England [28]. Details of 94 
the ELSA methodology have been published previously [29]. The ELSA sample (n=18,489) 95 
was derived from respondents to the Health Survey for England (HSE), who are re-96 
interviewed at biennial intervals (waves) to assess changes in their health, economic and 97 
social circumstances. The first wave consisted of those aged 50 or older on March 1st 2002, 98 
and their partners, with the final wave commencing on June 1st 2014 (Table 1). Respondents 99 
were given a self-completion questionnaire containing details such as smoking history, 100 
alcohol history and physical activity levels. At waves 3, 4, 6 and 7, new samples were 101 
obtained from the HSE to replenish the database [30]. At waves 2, 4 and 6, a nurse 102 
assessment took place in addition to the interviews, which assessed anthropometric 103 
measures and biological samples (e.g. cholesterol, glucose, cortisol), along with some tests 104 
of function, such as balance and strength measurements.  105 
Insert Table 1 here 106 
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The overall aim of this study was to assess the prospective association between 107 
receiving a diagnosis of cancer and experiencing a fall within two years, among older adults 108 
in England, using the ELSA database. A secondary aim was to compare the probability of 109 
falling among different cancer types to determine which cancers are associated with greater 110 
odds of falling. 111 
 112 
3 METHODS 113 
3.1 Study Design and Sample Selection 114 
This study was a secondary analysis of data obtained from the ELSA database using 115 
a prospective observational design. ELSA was approved by the London Multi-Centre 116 
Research Ethics Committee. All participants gave full informed consent to participate. 117 
Participants entered the dataset at different waves (every two years). For the current study, 118 
data for each participant was taken from the wave containing details of their initial 119 
assessment or the wave in which they received a diagnosis of cancer. Prospective falls data 120 
were used; therefore, falls data were recorded if a person partook in the wave following their 121 
initial assessment (two years later) to ensure a fall succeeded the cancer diagnosis (e.g. if 122 
someone entered the study at wave 3, follow-up data would be derived from the wave 4 123 
assessment two years later).  124 
 125 
3.2 Eligibility Criteria 126 
Data were extracted from waves 1-7 (2002-2014). Only participants aged 60 years or 127 
older were eligible, due to falls information being collected from this age onwards. 128 
Participants were divided into two groups: 1) Exposed group: Individuals who had received a 129 
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diagnosis of cancer; and 2) Unexposed group: Those who had not received a diagnosis of 130 
cancer.  131 
The exposed group included those who were diagnosed with cancer at waves 1-6. 132 
Those who were diagnosed at wave 7 were not included as no follow-up data could be 133 
obtained. Those diagnosed more than two years prior to entering the study were excluded 134 
from all analysis. The cancer site was also collected. It was not possible to determine 135 
whether treatment provided included surgery, chemotherapy, radiotherapy, or a combination 136 
of these.  137 
The unexposed group included those who had not been diagnosed with cancer, 138 
chronic lung disease, asthma, arthritis, osteoporosis, Parkinson’s disease, Alzheimer’s 139 
disease, dementia, emotional, nervous or psychiatric problems, post-stroke, or congestive 140 
heart disease. Whilst there is no consensus on the definition of healthy older adults, previous 141 
literature has excluded similar conditions [31, 32, 33]. 142 
 143 
3.3 Outcome Measure 144 
The outcome for this analysis was whether a fall had occurred in the two years after 145 
the baseline data collection wave (following a recent diagnosis of cancer for the exposed 146 
group). Self-reported data on falls were collected. Participants were asked ‘Have you fallen 147 
down in the last two years (for any reason)?’. In the current study, falls were treated as a 148 
binary (yes or no) outcome, irrespective of frequency or whether medical treatment was 149 
required, due to the medical treatment option being open to interpretation.  150 
 151 
3.4 Covariates 152 
Age, sex, wealth, and education level were considered to be causes of exposure 153 
(cancer) and outcome (falls) and were included in the analysis as covariates to reduce 154 
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confounding and bias [34, 35]. Wealth was derived using the total net financial wealth 155 
variable extracted from the wave in which the participants with cancer were diagnosed, or at 156 
inception for those in the unexposed group. Education level was classified using the highest 157 
educational qualification attained, which was categorised into lower (No qualifications), 158 
intermediate (Qualifications below college degree) and higher (College degree or above) 159 
education [36, 37, 38]. Wealth and education have both been reported as valid proxies of 160 
socio-economic status [37, 38, 39]. 161 
 162 
3.5 Statistical Analysis 163 
Unadjusted, partially adjusted (age and sex) and fully adjusted (age, sex, education, 164 
and wealth) logistic regression analyses were conducted. The results from all three models 165 
are presented, with emphasis on the full model. The odds ratio was derived for the 166 
association between recent cancer diagnosis and falls incidence, together with its 2-sided 167 
95% confidence interval. The confidence interval reveals the range of associations 168 
compatible with the data and model. A priori, an odds ratio of 1.5 (or its reciprocal of 0.67 for 169 
an effect in the opposite direction) was identified as the smallest association of interest. 170 
Therefore, the interval bounded by these values was considered as the region of practical 171 
equivalence of the exposed and unexposed groups; effect sizes within these limits are 172 
considered trivial. At the expected fall incidence in the current analysis, an odds ratio of 1.5 173 
represents a difference in the probability of falling between exposed and unexposed groups 174 
of approximately ten percentage points: one more person in every ten experiencing a fall 175 
with cancer versus without cancer. An odds ratio of 1.5 is equivalent to a standardised mean 176 
difference of around 0.2 – a small effect size. The disposition of the derived 95% confidence 177 
interval to the region of practical equivalence may be used to rule out meaningful effects in 178 
either direction (greater fall incidence in exposed or unexposed), equivalent to two 1-sided 179 
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tests each at the 0.025 alpha level. In brief, if the entire 95% confidence interval for the odds 180 
ratio lies between 0.67 and 1.5, then the groups may be considered statistically equivalent. 181 
Data were analysed using Stata (StataCorp. 2015. Stata Statistical Software: 182 
Release 14. College Station, TX: StataCorp LP). Under a plausible missing at random 183 
assumption, multiple imputation with chained equations was used to impute missing data 184 
such that these cases could be included appropriately in the analysis. The education data 185 
were imputed using ordinal logistic regression from age, sex, wealth, and the outcome 186 
variable and wealth data were imputed using predictive mean matching (random selection 187 
from 10 nearest neighbours) from age, sex, education, and the outcome variable. Twenty-188 
five imputations were conducted, and the logistic regression analysis model was then 189 
applied to the 25 imputed data sets, with results combined conventionally using Rubin’s 190 
rules [40]. For the full analysis model, odds were converted to probabilities of falling in 191 
exposed and unexposed groups. These probabilities were derived at the mean value of 192 
continuous covariates, with factor variables treated as balanced.  193 
Data were analysed without accounting for survey design, as sampling fractions are 194 
not relevant when the objective is to explore ‘causal’ relationships between exposure and 195 
outcome [41].  196 
 197 
4 RESULTS 198 
Those in the exposed group (n=139) had a mean (standard deviation (SD)) age of 70.6 199 
(7.1) years, with 58.3% male. The unexposed group (n=3,899) consisted of individuals aged 200 
69.5 (7.3) years, with 54.6% male. The flow diagram of participants in the current secondary 201 
analysis is shown in Figure 1. Sample characteristics for the exposed and unexposed groups 202 
are shown in Table 2. There were no substantial differences in age, sex distribution, wealth, 203 
or education level between the two groups. Nineteen participants had missing data for 204 
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wealth, whilst 414 were missing a value for education, with 431 having at least one of these 205 
two variables missing. 206 
Insert Figure 1 here 207 
Insert Table 2 here 208 
The odds ratios are displayed in Table 3 and are similar for all three models. The 209 
confidence interval includes the smallest odds ratio of interest of 1.5, and therefore a 210 
meaningful association between cancer diagnosis and increased odds of falling cannot be 211 
ruled out – the groups are not statistically equivalent. A meaningful association in the 212 
opposite direction (substantially higher fall incidence in the unexposed group) can be ruled 213 
out at the 2.5% alpha level, as the lower limit of the 95% confidence interval was >0.67. The 214 
point estimate, however, is a trivial effect size, and the confidence interval shows that 215 
associations ranging from trivial negative (greater odds of falling in the unexposed group) to 216 
small positive are compatible with the data and model. From the fully adjusted model, the 217 
predicted probability of a fall (derived directly from the odds) in the exposed group is 22.7% 218 
(95% CI: 16 to 30%) versus 19.5% (18 to 21%) in the unexposed group. 219 
Insert Table 3 here 220 
Our secondary aim was to explore the probability of falling across different cancer 221 
types. This, however, was not possible due to the low total number of people in the exposed 222 
group (n=139). Furthermore, limited information was available on the site of the cancer, with 223 
over 50% classified as ‘somewhere else’.   224 
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5 DISCUSSION 225 
The primary study aim was to assess the association between receiving a diagnosis 226 
of cancer and experiencing a fall within a two-year period. The point estimate for the odds 227 
ratio was a trivial effect size, but the confidence interval revealed that a meaningful small 228 
positive association was compatible with the data; therefore, the groups were not statistically 229 
equivalent. A secondary aim was to compare the probability of falling among different cancer 230 
types; however, this could not be explored due to the small number of people diagnosed with 231 
cancer.  232 
The probability of the exposed and unexposed group in this sample experiencing a fall 233 
is only around one in five. Previous research has shown a substantially higher probability of 234 
falling in older adults of the same age without cancer [13, 42, 43]. This discrepancy might be 235 
due to the unexposed group in the current study consisting of those with no chronic 236 
conditions; arguably our sample is healthier than those in other research which includes 237 
participants with a variety of conditions or comorbidities. By excluding these individuals from 238 
the analysis, we can then explore the incidence of falls between people with cancer and 239 
healthy controls, reducing confounding and bias in the study. Furthermore, our exposed 240 
group includes those with cancers associated with lower risks of falls and unspecified 241 
cancers. Hence, the falls incidence in the cancer group might have been higher if our sample 242 
had consisted of more people with cervical, uterine, breast, prostate, or lung cancer, as 243 
previous studies have shown these individuals are more likely to fall than those with other 244 
cancer diagnoses [44, 45, 46, 47]. It is unclear, however, what causes falls in these 245 
populations, although balance and gait impairments due to cancer symptoms and side-246 
effects of surgery and associated treatments might be implicated. The nature and timing of 247 
cancer treatment is also unclear from the ELSA database. Cancer treatments, such as 248 
chemotherapy, can increase risk of falls by having a negative effect on postural control [48, 249 
49]. Chemotherapy-induced peripheral neuropathy can cause impaired motor and sensory 250 
function through the neurotoxic effects of chemotherapy drugs [50, 51]. Sensory symptoms 251 
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include loss of sensation, ataxia and pain, whilst motor symptoms include weakness and 252 
balance disturbances [50, 51, 52], which in turn may contribute to an increased fall risk. 253 
Other covariates were considered in this analysis, such as body mass index (BMI), 254 
balance, strength, pain, ethnicity, smoking and alcohol consumption. Although balance, 255 
strength and pain are causes of falls, they do not cause cancer; therefore, they were not 256 
adjusted for in the analysis. BMI was not included as anthropometric data were only 257 
collected at nurse waves or fed-forward from the HSE, which means BMI could not be 258 
calculated at a true baseline [40]. Ethnicity was also considered as this has been shown to 259 
influence fall and cancer risk. In the ELSA database, however, ethnicity was classified as 260 
‘white’ or ‘non-white’ which has been reported as being a limitation due to the lack of 261 
variability and sub-classification of ethnicity [41]. Smoking habits were not included in the 262 
analysis as this exposure is not causally related to falls; however, it does cause osteoporosis 263 
[42] which is associated with an increased fall risk [43]. It was also not possible to quantify 264 
the amount smoked as no date for stopping smoking is reported in the database, and thus 265 
pack years could not be calculated. Smoking status was also self-reported, potentially 266 
biasing any analysis [44]. Alcohol consumption was not included due to the way this was 267 
reported. In wave 1, these variables noted the frequency that an individual drinks alcohol 268 
within the last 12 months and current drinking habits. However, there is no report on the 269 
quantity of alcohol consumed. 270 
 271 
5.1 Limitations 272 
This is the first study to perform an analysis of this kind to explore the incidence of 273 
falling in people in England with a diagnosis of cancer versus a sample with no chronic 274 
conditions. We must acknowledge several limitations. The sample size for the exposed 275 
group is small, precluding exploration of the association between individual cancer types and 276 
fall incidence. With the number eligible for inclusion and the small proportion of exposed 277 
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cases, our study had only around 50% power to detect an odds ratio of 1.5 – the smallest 278 
association of interest. However, our study is explicitly labelled as exploratory, and further 279 
research is required to define the association more precisely. The falls data in the ELSA 280 
database were self-reported, which might mean that falls are under-reported due to recall 281 
issues in older adults [53, 54]. Although cognitive impairment was not considered in this 282 
study, the issue of recall bias is important to consider when interpreting results of this nature, 283 
especially among older adult populations. Additionally, what constitutes a fall was not 284 
defined explicitly in the ELSA questionnaire, leading to potential misinterpretation and 285 
reporting errors [55]. These issues with the reporting of falls might also contribute to the 286 
discrepancy between the fall incidence observed in our analysis compared with the higher 287 
incidence reported in previous literature.  288 
With respect to cancer diagnoses, the timeframe of two years might also be a 289 
limitation. One individual may have been diagnosed with a minor cancer almost two years 290 
prior to entering the study and be back to full health, whilst another may have had a 291 
diagnosis of a more aggressive cancer a couple of months prior to inclusion. We were also 292 
unable to assess what treatment individuals had undergone, which could affect the incidence 293 
of falls due to the side-effects of surgery and adjuvant therapy. The medication that 294 
individuals were taking was also not adjusted for in this analysis due to this only being 295 
collected at nurse waves (every four years).  296 
This study was a secondary analysis; therefore, we had no control over the variables 297 
which were collected or the way in which they were collected. People with cancer in this 298 
analysis might also have had other comorbidities, therefore, it is possible that one or more of 299 
these comorbidities might have contributed to fall risk. However, cancer is the one condition 300 
that all participants had in common.  301 
  302 
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5.2 Recommendations 303 
Our exploratory analysis contributes to the current knowledge base within this area 304 
by adding to the scarce literature investigating falls among people with cancer. A meaningful 305 
small positive association between cancer diagnosis and fall incidence could not be ruled out 306 
statistically, suggesting that further research is warranted. Our work also helps to guide 307 
research on falls among people with cancer in England by highlighting the limitations of the 308 
current study that should be considered in future research, including recall bias and the 309 
inability to include covariates such as BMI and polypharmacy. A larger sample size (more 310 
exposed cases) with more information on people with cancer is needed to reduce bias and 311 
more precisely define the association between recent cancer diagnoses and fall incidence. It 312 
is also essential to know more about the cancer, such as stage, mode of treatment, and 313 
timing, to examine the influence of these factors on falls.  314 
 315 
6 CONCLUSION 316 
In this secondary analysis, the confidence interval for the odds ratio for experiencing 317 
a fall revealed that the range of effect sizes compatible with the data and model ranged from 318 
trivially negative (higher incidence of falling in controls) to a meaningful positive association 319 
between cancer diagnosis and fall incidence. The two groups were not statistically 320 
equivalent, as the upper confidence limit for the odds ratio was beyond the smallest effect 321 
size of interest of 1.5, indicating that a greater incidence of falls in the cancer group could 322 
not be ruled out. Further research is required to elucidate this relationship. 323 
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7 LIST OF ABBREVIATIONS 327 
BMI: Body mass index; ELSA: English Longitudinal Study of Ageing; HSE: Health Survey for 328 
England  329 
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1 2002   11 391 
2 2004  Yes 8 780 
3 2006 Yes  8 810 
4 2008 Yes Yes 9 886 
5 2010   9 090 
6 2012 Yes Yes 9 169 
7 2014 Yes  8 249 
 360 
 361 















 Exposed (n=139) Unexposed (n=3 899) 
Age (Years) Mean (SD) 70.6 (7.1) 69.5 (7.3) 
Male sex 58.3% 54.6% 
Wealth (£) median 
(interquartile range) 
(n=137)  
23 100 (3 500 to 92 500)  
(n=3 882)  
18 000 (3 006 to 62 060)  
Education (n=126) (n=3 498) 
No qualification 48.4% 47.6% 
Intermediate 16.7% 21.8% 
Higher 34.9% 30.6% 
Type of Cancer   
Lung 4.3%  
Breast 18.7%  
Colon, rectum or 
bowel 
14.4%  
Lymphoma 2.9%  
Leukaemia 0.7%  
Melanoma or skin 7.2%  
Somewhere else 51.8%  





Table 3. The association between recent cancer diagnosis and falling: odds ratio (95% 376 
confidence interval (CI)) for experiencing a fall during follow up in the exposed versus 377 
unexposed group. 378 
 Model 1  
(Unadjusted) 
Model 2  
(Part-Adjusted) 









Part-adjusted model (age and sex); Fully adjusted model (age, sex, education, wealth) 379 





Figure 1. Flow diagram of participant numbers included within the study 383 
Exposed=Received a diagnosis of cancer; Unexposed=No diagnosis of cancer 384 
 385 
Number in ELSA 
database 
n=18 489 
≥60 years old and 
exposed ≤2 year 
ago 
n=142 
With falls data 
n=139 
≥60 years old and 
unexposed 
n=4 019 
With falls data 
n=3 899 
No falls data 
n=3 excluded 










<60 years old  
n=5 654 excluded 
